UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cutaneous Manifestations of Human and Murine Leishmaniasis

International journal of molecular sciences, 2017-06, Vol.18 (6), p.1296

2017

Volltextzugriff (PDF)

CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions

PLoS pathogens, 2024-05, Vol.20 (5), p.e1012211

2024

Volltextzugriff (PDF)

CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production

PLoS pathogens, 2017-02, Vol.13 (2), p.e1006196-e1006196

2017

Volltextzugriff (PDF)

The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis

PloS one, 2016-02, Vol.11 (2), p.e0148084-e0148084

2016

Volltextzugriff (PDF)

Association of Intestinal Helminthiasis with Disseminated Leishmaniasis, Brazil

Emerging infectious diseases, 2024-09, Vol.30 (9), p.1970-1972

2024

Volltextzugriff (PDF)

Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis

Science translational medicine, 2019-11, Vol.11 (519)

2019

Volltextzugriff (PDF)

TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals

Frontiers in immunology, 2022-10, Vol.13, p.954103-954103

2022

Volltextzugriff (PDF)

IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection

PLoS pathogens, 2013-03, Vol.9 (3), p.e1003243-e1003243

2013

Volltextzugriff (PDF)

Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection

Emerging infectious diseases, 2024-03, Vol.30 (3), p.510-518

2024

Volltextzugriff (PDF)

Short communication: The miR-155a-5p is correlated with increased ROS and impaired apoptosis in macrophages infected by Leishmania braziliensis

PloS one, 2024-02, Vol.19 (2), p.e0298458-e0298458

2024

Volltextzugriff (PDF)

Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis

The Journal of infectious diseases, 2020-03, Vol.221 (6), p.973-982

2020

Volltextzugriff (PDF)

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial

PLoS neglected tropical diseases, 2023-02, Vol.17 (2), p.e0011064-e0011064

2023

Volltextzugriff (PDF)

NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis

PLoS neglected tropical diseases, 2023-08, Vol.17 (8), p.e0011552-e0011552

2023

Volltextzugriff (PDF)

Bladder dysfunction in human T cell lymphotropic virus infection: A prospective cohort study

PLoS neglected tropical diseases, 2022-01, Vol.16 (1), p.e0009772-e0009772

2022

Volltextzugriff (PDF)

Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis

The American journal of tropical medicine and hygiene, 2017-01, Vol.96 (3), p.645-652

2017

Volltextzugriff (PDF)

Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion

PLoS neglected tropical diseases, 2016-09, Vol.10 (9), p.e0004992-e0004992

2016

Volltextzugriff (PDF)

Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis

International journal of infectious diseases, 2021-05, Vol.106, p.83-90

2021

Volltextzugriff (PDF)

Serial Quantitative PCR Assay for Detection, Species Discrimination, and Quantification of Leishmania spp. in Human Samples

Journal of Clinical Microbiology, 2011-11, Vol.49 (11), p.3892-3904

2011

Volltextzugriff (PDF)

Protective and pathologic immune responses in human tegumentary leishmaniasis

Frontiers in immunology, 2012-01, Vol.3, p.301-301

2012

Volltextzugriff (PDF)

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial

PLoS neglected tropical diseases, 2010-12, Vol.4 (12), p.e912

2010

Volltextzugriff (PDF)

IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis

PloS one, 2015-08, Vol.10 (8), p.e0134698-e0134698

2015

Volltextzugriff (PDF)

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects

PLoS neglected tropical diseases, 2016-12, Vol.10 (12), p.e0005100-e0005100

2016

Volltextzugriff (PDF)

Protection and Pathology in Leishmania braziliensis Infection

Pathogens (Basel), 2022-04, Vol.11 (4), p.466

2022

Volltextzugriff (PDF)

Leishmania braziliensis exosomes activate human macrophages to produce proinflammatory mediators

Frontiers in immunology, 2023-09, Vol.14, p.1256425-1256425

2023

Volltextzugriff (PDF)

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial

PLoS neglected tropical diseases, 2023-04, Vol.17 (4), p.e0011261-e0011261

2023

Volltextzugriff (PDF)

1 – 25 von 543

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(516)
Mit Volltextzugriff
(486)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Cutaneous Manifestations of Human and Murine Leishmaniasis

CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions

CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production

The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis

Association of Intestinal Helminthiasis with Disseminated Leishmaniasis, Brazil

Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis

TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals

IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection

Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection

Short communication: The miR-155a-5p is correlated with increased ROS and impaired apoptosis in macrophages infected by Leishmania braziliensis

Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial

NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis

Bladder dysfunction in human T cell lymphotropic virus infection: A prospective cohort study

Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis

Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion

Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis

Serial Quantitative PCR Assay for Detection, Species Discrimination, and Quantification of Leishmania spp. in Human Samples

Protective and pathologic immune responses in human tegumentary leishmaniasis

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial

IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects

Protection and Pathology in Leishmania braziliensis Infection

Leishmania braziliensis exosomes activate human macrophages to produce proinflammatory mediators

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial

Suchergebnisse filtern